BRIEF-Glaxosmithkline reaches $105 million settlement with most U.S. states over marketing of drugs

June 4 Wed Jun 4, 2014 12:15pm EDT

June 4 (Reuters) - GlaxoSmithKline PLC : * Reaches $105 million settlement with most U.S. states over marketing of

various prescription drugs -- U.S. authorities * California, New York attorneys general say settlement resolves allegations

that company unlawfully promoted advair, paxil, wellbutrin * Attorneys general say glaxo settles with 44 U.S. states, Washington d.c.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.